SS
State Street Corp disclosed a 7% stake in SRPT
State Street Corp reported owning 7% of Sarepta Therapeutics, Inc. (SRPT) (7,412,275 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 10, 2026
- Source
- Schedule 13G